Rubius Therapeutics developed our proprietary RED PLATFORMŽ to generate red blood cells and genetically engineer them into a new class of cellular medicines, called Red Cell Therapeutics⢠(RCTs). Our RED PLATFORM harnesses both the unique properties of red blood cells and the creative potential of genetic engineering to deliver on the promise of cellular therapy and transform how diseases are treated. Red Cell Therapeutics are engineered to express biotherapeutic proteins within or on their cell surface to create highly selective, potent and allogeneic cellular medicines aimed at treating a range of diseases. They can potentially be used to replace missing enzymes for patients living with certain rare enzyme deficiencies, kill tumors in cancer and regulate the immune system for the treatment of autoimmune diseases. The U.S. Food and Drug Administration cleared the Investigational New Drug application (IND) for our first clinical candidate, RTX-134, for the treatment of phenylketonuria. Additionally, we plan to file an IND by early 2020 for our lead cancer program, RTX-240 (formerly RTX-212), for the treatment of solid tumors. In total, we plan to file four to five INDs in 2019 and 2020. Source
No articles found.
As the leader womenâs health, we deliver life-changing and life-saving diagnosti...
As the leader womenâs health, we deliver life...
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on a...
Concert Pharmaceuticals is a clinical stage bio...
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on ...
Organogenesis Holdings Inc. is a leading regene...
Lonza is an integrated solutions provider that creates value along the Healthcare ...
Lonza is an integrated solutions provider that ...
Cancer is one of the most difficult diseases to treat. It is constantly changing, ...
Cancer is one of the most difficult diseases to...
We are a biopharmaceutical company focused on developing our pipeline featuring sp...
We are a biopharmaceutical company focused on d...
Pluristem Therapeutics Inc. is a clinical-stage biotherapy company using placental...
Pluristem Therapeutics Inc. is a clinical-stage...
Join the National Investor Network and get the latest information with your interests in mind.